Altered iron metabolism as a target for ferroptosis induction in head and neck cancer

被引:0
作者
Jaewang Lee
Jong-Lyel Roh
机构
[1] CHA Bundang Medical Center,Department of Otorhinolaryngology
[2] CHA University,Head and Neck Surgery
[3] CHA University,Department of Biomedical Science, General Graduate School
来源
Cellular Oncology | 2023年 / 46卷
关键词
Iron; Labile iron pool; Ferroptosis; Regulators; Head and neck cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Iron is a mineral micronutrient essential for survival and vital functions in many biological processes in living organisms. Iron plays a crucial role as a cofactor of iron-sulfur clusters in energy metabolism and biosynthesis by binding with enzymes and transferring electrons to targets. Iron can also impair cellular functions by damaging organelles and nucleic acids by producing free radicals from redox cycling. Iron-catalyzed reaction products can induce active-site mutations in tumorigenesis and cancer progression. However, the boosted pro-oxidant iron form may contribute to cytotoxicity by increasing soluble radicals and highly reactive oxygen species via the Fenton reaction. An increased redox-active labile iron pool is required for tumor growth and metastasis, but the increased cytotoxic lipid radicals also lead to regulated cell death, such as ferroptosis. Therefore, this may be a major target for selectively killing cancer cells. This review intends to understand altered iron metabolism in cancers and discuss iron-related molecular regulators highly associated with iron-induced cytotoxic radical production and ferroptosis induction, focusing on head and neck cancer.
引用
收藏
页码:801 / 810
页数:9
相关论文
共 50 条
[31]   MERTK as a novel therapeutic target in head and neck cancer [J].
von Maessenhausen, Anne ;
Sanders, Christine ;
Thewes, Britta ;
Deng, Mario ;
Queisser, Angela ;
Vogel, Wenzel ;
Kristiansen, Glen ;
Duensing, Stefan ;
Schroeck, Andreas ;
Bootz, Friedrich ;
Brossart, Peter ;
Kirfel, Jutta ;
Heasley, Lynn ;
Braegelmann, Johannes ;
Perner, Sven .
ONCOTARGET, 2016, 7 (22) :32678-32694
[32]   Induction chemotherapy for locally advanced head and neck cancer [J].
Calais, G. ;
Chapet, S. ;
Ruffier-Loubiere, A. ;
Bernadou, G. .
CANCER RADIOTHERAPIE, 2013, 17 (5-6) :498-501
[33]   Induction chemotherapy in head and neck cancer: a new paradigm [J].
Pointreau, Yoann ;
Atean, Ibrahim ;
Fayette, Jerome ;
Calais, Gilles ;
Lefebvre, Jean Louis .
ANTI-CANCER DRUGS, 2011, 22 (07) :613-620
[34]   Role of induction chemotherapy in head and neck cancer: Cons [J].
Huguet, F. ;
Schick, U. ;
Pointreau, Y. .
CANCER RADIOTHERAPIE, 2017, 21 (6-7) :510-514
[35]   Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis [J].
Wu, Yang-Che ;
Huang, Chin-Sheng ;
Hsieh, Ming-Shou ;
Huang, Chih-Ming ;
Setiawan, Syahru Agung ;
Yeh, Chi-Tai ;
Kuo, Kuang-Tai ;
Liu, Shao-Cheng .
AGING-US, 2024, 16 (01) :627-647
[36]   Research progress on ferroptosis in head and neck squamous cell carcinoma [J].
Qiu, Yi ;
Su, Yuyuan ;
Sai, Wenli ;
Feng, Guijuan .
JOURNAL OF MOLECULAR HISTOLOGY, 2025, 56 (02)
[37]   Induction and application of ferroptosis in cancer therapy [J].
Nie, Qing ;
Hu, Yue ;
Yu, Xiao ;
Li, Xiao ;
Fang, Xuedong .
CANCER CELL INTERNATIONAL, 2022, 22 (01)
[38]   Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer [J].
Roh, Jong-Lyel ;
Kim, Eun Hye ;
Jang, Hye Jin ;
Park, Jin Young ;
Shin, Daiha .
CANCER LETTERS, 2016, 381 (01) :96-103
[39]   Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer [J].
Lee, Jaewang ;
You, Ji Hyeon ;
Roh, Jong-Lyel .
REDOX BIOLOGY, 2022, 51
[40]   Prognostic risk modeling of head and neck cancer based on ferroptosis and drug sensitivity analysis of related genes [J].
Zhu, Chaofeng ;
Liang, Yufen .
PROCEEDINGS OF 2024 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND INTELLIGENT COMPUTING, BIC 2024, 2024, :460-467